A detailed history of Cwm, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Cwm, LLC holds 362 shares of NAUT stock, worth $644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
362
Previous 243 48.97%
Holding current value
$644
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$2.24 - $3.08 $266 - $366
119 Added 48.97%
362 $1,000
Q2 2024

Jul 09, 2024

BUY
$2.22 - $3.0 $532 - $720
240 Added 8000.0%
243 $1,000
Q1 2024

Apr 05, 2024

BUY
$2.41 - $3.18 $7 - $9
3 New
3 $0
Q3 2022

Oct 27, 2022

BUY
$1.96 - $3.13 $627 - $1,001
320 New
320 $1,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $222M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.